|
KMID : 0361020210640060626
|
|
Korean Journal of Otolaryngology - Head and Neck Surgery
2021 Volume.64 No. 6 p.626 ~ p.634
|
|
|
Tumor Necrosis Factor-Alpha and Interleukin-4 Levels in Patients With Idiopathic Sudden Sensorineural Hearing Loss
|
|
Kim Yun
Kim Su-Jong
Choi Seok-Youl
Moon Jee-Won
Choi June
Im Gi-Jung
Chae Sung-Won
Song Jae-Jun
|
|
|
Abstract
|
|
|
Background and Objectives The pathogenesis of idiopathic sudden sensorineural hearingloss (ISSNHL), an otologic emergency disease, remains unclear. Several studies have attemptedto illustrate the association between cytokines and ISSNHL. The purpose of this study wasto evaluate the prognostic significance of various cytokines in patients with ISSNHL.
Subjects and Method In this case-control study, a total of 55 patients with ISSNHL underwenttreatment with oral prednisolone for 2 weeks. Serum cytokine levels, including interleukins(ILs) (IL-1a, IL-1b, IL-2, IL-4, IL-6, IL-7, IL-8, IL-10, IL-12), and tumor necrosis factors(TNF-α and TNF-β), were measured using human cytokine panels at first visit. Patient characteristicssuch as age, gender, the status of hypertension, diabetes mellitus, vertigo, timefrom onset to visit, and initial hearing levels were also evaluated.
Results Serum levels of cytokines were correlated with the prognosis of ISSNHL patients.
IL-4 ≥0.225 (pg/mL) and TNF-α ≥5.155 (pg/mL) were significantly associated with poor therapeuticoutcomes (OR=44.317, p=0.015 and OR=269.465, p=0.006, respectively). In addition,age and initial hearing levels were also significant prognostic factors.
Conclusion Patients’ age, initial hearing levels, and serum levels of IL-4 and TNF-α prior totreatment are associated with hearing recovery and can be used as prognostic factors for patientswith ISSNHL.
|
|
|
KEYWORD
|
|
|
Interleukins, Sensorineural hearing loss, Sudden deafness, Tumor necrosis factor-alpha
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|
|